Surmodics reported $12.85M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Align Technology ALGN:US $ 426.4M 13.06M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Baxter International BAX:US $ 817M 27M
Bioscrip BIOS:US $ 141.79M 7.82M
Boston Scientific BSX:US $ 1.16B 105M
Cryolife CRY:US $ 38.05M 1.71M
Edap Tms EDAP:US 4.79M 401K
Edwards Lifesciences EW:US $ 409M 38.7M
Haemonetics HAE:US $ 93.17M 7.62M
Heron Therapeutics HRTX:US $ 32.12M 836K
Johnson & Johnson JNJ:US $ 6.23B 288M
Merit Medical Systems MMSI:US $ 85.49M 1.47M
Mesa Laboratories MLAB:US $ 27.74M 2.3M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Stryker SYK:US $ 1.46B 44M
Surmodics SRDX:US $ 12.85M 1.74M
Trinity Biotech TRIB:US 6.13M 572K